济民制药 (603222.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(济民制药)

导出到EXCEL
报表范围选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
关 闭
完整财报对比
2018年三季报2018年中报2018年一季报2017年年报2017年三季报2017年中报2017年一季报2016年年报2016年三季报2016年中报2016年一季报
主要指标:
 营业收入(元) 539,380,840.18349,208,852.93164,295,406.81602,898,708.81450,540,814.67284,334,053.62133,224,729.02450,378,618.80328,971,057.08207,965,317.99102,555,770.22
 营业利润(元) 63,551,529.5047,415,590.1316,756,740.1674,121,453.5754,580,315.6027,824,470.3911,496,853.3947,082,225.3330,701,238.7015,961,531.788,367,688.37
 利润总额(元) 62,349,002.7146,588,781.3816,341,974.7070,999,654.9351,966,597.5826,464,017.7411,668,276.5347,651,256.6429,060,154.9915,001,529.108,424,929.81
 净利润(元) 48,841,129.9534,647,130.5211,794,753.7555,894,317.9841,653,148.8920,869,280.298,922,564.2739,627,650.6924,643,524.2512,132,274.996,623,137.22
 归属于母公司股东的净利润(元) 36,912,156.4228,415,679.8811,213,798.9252,884,359.8339,951,863.6019,997,060.308,666,820.2040,893,904.7525,529,030.5412,818,198.676,802,293.56
盈利能力:
 销售毛利率(%) 44.8745.2743.7045.0044.5743.8942.6345.4545.3244.0443.80
 销售净利率(%) 9.069.927.189.279.257.346.708.807.495.836.46
 净资产收益率(%) 4.633.631.436.855.272.701.17----
 总资产报酬率ROA(%) 4.553.361.496.825.513.011.39----
 投入资本回报率ROIC(%) 2.632.220.965.514.352.200.985.423.411.740.92
营运能力:
 存货周转率(次) 3.022.010.973.462.731.880.89----
 应收账款周转率(次) 2.631.870.924.172.771.950.87----
 总资产周转率(次) 0.320.210.120.480.400.260.13----
偿债能力:
 资产负债率(%) 47.1747.3339.7141.0632.6932.7930.5812.3011.979.979.56
 股东权益比率(%) 40.8840.8650.9050.3858.1858.2762.3681.4482.6484.4084.76
 已获利息倍数(倍) 5.616.484.636.006.425.345.24-12.58-15.07-9.01703.45
 流动比率 0.920.911.110.971.651.852.355.335.766.977.02
 速动比率 0.700.720.840.751.231.411.814.264.615.795.89
发展能力:
 营业收入增长率(%) 19.7222.8223.3233.8636.9536.7229.900.40-4.76-7.07-9.72
 营业利润增长率(%) 16.4470.4138.7157.4377.7874.3237.40-23.40-35.72-42.19-42.62
 税后利润增长率(%) -7.6142.1029.3929.3256.5056.0127.41-20.97-34.69-42.73-38.39
 净资产增长率(%) 4.445.895.875.625.985.114.394.193.994.603.34
 总资产增长率(%) 48.6651.0129.7070.7450.5252.2441.899.2912.4510.559.46

IPO咨询服务